145. ウエスト症候群 West syndrome Clinical trials / Disease details
臨床試験数 : 43 / 薬物数 : 54 - (DrugBank : 15) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 24
Showing 1 to 10 of 43 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05279118 (ClinicalTrials.gov) | March 2022 | 3/3/2022 | Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome | Comparison of Efficacy of Ketogenic Diet and ACTH Therapy Among Children With West Syndrome: A Pilot Randomized Control Trial Comparison of Efficacy of Ketogenic Diet and ACTH Therapy Among Children With West Syndrome: A Pilot ... | Ketogenic Diet;West Syndrome;Infantile Spasm;ACTH | Dietary Supplement: Ketogenic diet;Drug: ACTH | All India Institute of Medical Sciences, New Delhi | NULL | Not yet recruiting | 6 Months | 2 Years | All | 80 | Phase 2/Phase 3 | India |
2 | NCT04727970 (ClinicalTrials.gov) | November 1, 2021 | 19/1/2021 | Tricaprilin Infantile Spasms Pilot Study | A Phase I Open-Label Pilot Study to Investigate the Feasibility, Safety, Tolerability and Efficacy of Daily Administration of Tricaprilin in Subjects With Infantile Spasms A Phase I Open-Label Pilot Study to Investigate the Feasibility, Safety, Tolerability and Efficacy o ... | Infantile Spasm | Drug: Tricaprilin | Cerecin | NULL | Recruiting | 3 Months | 24 Months | All | 10 | Phase 1 | Australia;Singapore |
3 | ChiCTR2100045702 | 2021-04-21 | 2021-04-23 | Observation on the clinical effect of vigabatrin plus vitamin B1 in the treatment of infantile spasms Observation on the clinical effect of vigabatrin plus vitamin B1 in the treatment of infantile spasm ... | Observation on the clinical effect of vigabatrin plus vitamin B1 in the treatment of infantile spasms Observation on the clinical effect of vigabatrin plus vitamin B1 in the treatment of infantile spasm ... | infantile spasms | experimental group:Use vitamin B1;control group:Vitamin B1 is not used ; | Faculty of Pediatrics, the first Medical Centre, Chinese PLA General Hospital | NULL | Recruiting | Both | experimental group:10;control group:10; | China | |||
4 | ChiCTR2000036208 | 2020-10-31 | 2020-08-21 | Melatonin as add-on treatment for infantile spasms | Melatonin supplementation in the treatment of infantile spasms: a randomized placebo-controlled triple-blind trial Melatonin supplementation in the treatment of infantile spasms: a randomized placebo-controlled trip ... | Infantile spasm | melatonin group:add melatonin;placebo group:add placebo; | Department of Pediatrics, The First Medical Center, General Hospital of the People's Liberation Army of China Department of Pediatrics, The First Medical Center, General Hospital of the People's Liberation Army ... | NULL | Recruiting | 3? | 2 | Both | melatonin group:35;placebo group:35; | China | |
5 | NCT04302116 (ClinicalTrials.gov) | May 18, 2020 | 5/3/2020 | Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm | Efficacy of Vigabatrin With High Dose Prednisolone Combination Therapy Versus Vigabatrin Alone for Infantile Spasm: a Randomized Trial Efficacy of Vigabatrin With High Dose Prednisolone Combination Therapy Versus Vigabatrin Alone for I ... | Infantile Spasm;West Syndrome | Drug: Combination therapy with vigabatrin and prednisolone;Drug: Vigabatrin Tablets | Kullasate Sakpichaisakul | NULL | Recruiting | 2 Months | 14 Months | All | 250 | N/A | Thailand |
6 | NCT04289467 (ClinicalTrials.gov) | April 1, 2020 | 21/2/2020 | Treatment of Refractory Infantile Spasms With Fenfluramine | A Phase II Study of Fenfluramine for Treatment of Refractory Infantile Spasms | Infantile Spasm | Drug: Fenfluramine | University of California, Los Angeles | NULL | Not yet recruiting | 3 Months | 36 Months | All | 10 | Phase 2 | United States |
7 | NCT03876444 (ClinicalTrials.gov) | April 1, 2019 | 12/3/2019 | Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms | Intravenous Methylprednisolone Versus High Dose Oral Prednisolone for the Treatment of Infantile Spasms: a Randomized Open-labelled Trial Intravenous Methylprednisolone Versus High Dose Oral Prednisolone for the Treatment of Infantile Spa ... | Infantile Spasm | Drug: Intravenous Methylprednisolone;Drug: Oral Pednisolone | Suvasini Sharma | NULL | Recruiting | 4 Months | 30 Months | All | 128 | Phase 2/Phase 3 | India |
8 | NCT03976076 (ClinicalTrials.gov) | March 1, 2019 | 31/5/2019 | A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients | A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Or ... | Refractory Infantile Spasms | Drug: JBPOS0101 | Bio-Pharm Solutions Co., Ltd. | NULL | Recruiting | 6 Months | 36 Months | All | 35 | Phase 2 | United States |
9 | NCT03421496 (ClinicalTrials.gov) | September 5, 2018 | 26/1/2018 | A Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms A Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution With Vigabatri ... | A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution as Adjunctive Therapy With Vigabatrin as Initial Therapy in Patients With Infantile Spasms A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, ... | Infantile Spasm | Drug: Cannabidiol Oral Solution;Drug: Placebo;Drug: Vigabatrin | Benuvia Therapeutics Inc. | NULL | Terminated | 1 Month | 24 Months | All | 2 | Phase 3 | United States |
10 | EUCTR2017-004775-30-FI (EUCTR) | 09/05/2018 | 08/05/2018 | PREDICTION AND PREVENTION OF INFANTILE SPASM SYNDROME IN HIGH RISK CHILDREN | PREDICTION AND PREVENTION OF INFANTILE SPASMS IN HIGH RISK CHILDREN - PREV-IS | Therapeutic area: Diseases [C] - Nervous System Diseases [C10] | Trade Name: Sabrilex Product Name: Sabrilex INN or Proposed INN: VIGABATRIN | Kirsi Mikkonen/Helsinki University Hospital | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 140 | Phase 4 | Finland |